According to Aethlon Medical
's latest financial reports the company has a price-to-book ratio of 0.4561.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.7173 | 96.13% |
2022-12-31 | 0.3657 | -73.75% |
2021-12-31 | 1.39 | -46.66% |
2020-12-31 | 2.61 | 115.82% |
2019-12-31 | 1.21 | -87.56% |
2018-12-31 | 9.73 | 162.53% |
2017-12-31 | 3.71 | -99.99% |
2016-12-31 | > 1000 | 156707.5% |
2015-12-31 | 19.1 | -71.79% |
2014-12-31 | 67.7 | -2108.22% |
2013-12-31 | -3.37 | 120.68% |
2012-12-31 | -1.53 | 60.81% |
2011-12-31 | -0.9502 | -40.56% |
2010-12-31 | -1.60 | -62.8% |
2009-12-31 | -4.30 | 69.79% |
2008-12-31 | -2.53 | -65.08% |
2007-12-31 | -7.25 | 170.26% |
2006-12-31 | -2.68 | 49.27% |
2005-12-31 | -1.80 | -14.66% |
2004-12-31 | -2.11 | 127.25% |
2003-12-31 | -0.9264 | -4.27% |
2002-12-31 | -0.9677 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
PerkinElmer
PKI | 1.80 | 294.54% | ๐บ๐ธ USA |
Pacific Biosciences
PACB | 0.6563 | 43.90% | ๐บ๐ธ USA |
Coherent
COHR | 0.9251 | 102.85% | ๐บ๐ธ USA |
Bruker BRKR | 8.13 | 1,681.97% | ๐บ๐ธ USA |
Accelerate Diagnostics AXDX | -1.02 | -323.40% | ๐บ๐ธ USA |
Inovio Pharmaceuticals INO | 2.56 | 461.03% | ๐บ๐ธ USA |